This study is in progress, not accepting new patients
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at UCSD UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- AbbVie
- Links
- Related info
- ID
- NCT03345823
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 747 study participants
- Last Updated